FDA Clearance Tracker · P170002-S048
RHA® Dynamic Volume, RHA®4
Last checked: Nov 20, 2026Latest source record: Sep 18, 2025 (this decision)Source: openFDAMethods & limitations
Decided
Sep 18, 2025
Approved
Time to decision
290 days
Received Dec 2, 2024. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Panel Track
Device class
Class III
The decision
- FDA number
- P170002-S048
- Device name
- RHA® Dynamic Volume, RHA®4
- Applicant
- Teoxane S.A.
- Applicant location
- Geneva
- Received
- Dec 2, 2024
- Decided
- Sep 18, 2025
- Decision
- Approved
- Supplement type
- Panel Track
- Reason for supplement
- Labeling Change - Indications/instructions/shelf life/tradename
- Original approval
- P170002
Device type
- Device type
- Implant, dermal, for aesthetic use (LMH)
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
Approval for RHA®4 and RHA® Dynamic Volume for expanding the indications to include injection into the subcutaneous to supraperiosteal layers for cheek augmentation and/or correction of age-related midface contour deficiencies in patients aged 22 or older.
Source documents
Other decisions for Teoxane S.A.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- RHA Redensity® Eye Lido; RHA Redensity® EyePMA supplement
P170002-S050 · Decided May 12, 2026 · 256 days after receipt · Panel Track
Device type: Implant, dermal, for aesthetic use (LMH) · General & Plastic Surgery
- RHA®3 dermal fillerPMA supplement
P170002-S030 · Decided Oct 27, 2023 · 179 days after receipt · Panel Track
Device type: Implant, dermal, for aesthetic use (LMH) · General & Plastic Surgery
- RHA® Redensity Mepi, RHA®2 Mepi, RHA®3 Mepi, RHA®4 MepiPMA supplement
P170002-S026 · Decided Oct 13, 2023 · 240 days after receipt · Panel Track
Device type: Implant, dermal, for aesthetic use (LMH) · General & Plastic Surgery
2 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.